Pharmaceutical giant AstraZeneca today unveiled a ten-year project to sequence the genomes of two million people — with top-tier medical and tech partnerships and a nine-figure price tag. The resulting database would be the largest of its kind, and would be used to hunt rare genes that may contribute to diseases. AstraZeneca is dipping into its own stores for the first big source of… Read More
Source: TechCrunch